drugset / Trial / NCT00859495

Trimodal Lung-Sparing Treatment of Pleural Mesothelioma

NCT00859495 ↗

Phase 2 Terminated 9 enrolled Columbia University
NaSingle-groupOpen-labelTreatment

Summary

The primary objective of the study is to determine the feasibility (as determined by lack of serious adverse events) and tolerability (as determined by patient's ability to complete the study) of a multimodal lung sparing regimen of surgery, interpleural and intravenous chemotherapy, and local P-32 irradiation for malignant pleural mesothelioma.

Timeline

Start
2008-02
Primary completion
2012-02
Completion
2012-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Cisplatin Other / unclassified — —
Subject Doxorubicin Other / unclassified — —
Subject Pemetrexed Small molecule — —